摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-氯喹啉-2,4-二羧酸 | 62482-33-1

中文名称
5-氯喹啉-2,4-二羧酸
中文别名
——
英文名称
5-chloroquinoline-2,4-dicarboxylic acid
英文别名
5-chloroquinolin-2,4-dicarboxylic acid;5-chloro-quinoline-2,4-dicarboxylic acid;5-Chlor-chinolin-2,4-dicarbonsaeure
5-氯喹啉-2,4-二羧酸化学式
CAS
62482-33-1
化学式
C11H6ClNO4
mdl
——
分子量
251.626
InChiKey
VSDOPAANGALBJB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    218-219 °C (decomp)
  • 沸点:
    480.3±45.0 °C(Predicted)
  • 密度:
    1.636±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.2
  • 重原子数:
    17
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    87.5
  • 氢给体数:
    2
  • 氢受体数:
    5

SDS

SDS:ca2a3dd529a83f880beb042f203b0f67
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    5-氯喹啉-2,4-二羧酸 为溶剂, 反应 2.0h, 生成 5-氯喹啉-4-甲酸
    参考文献:
    名称:
    Selective Inhibitors of Fibroblast Activation Protein (FAP) with a (4-Quinolinoyl)-glycyl-2-cyanopyrrolidine Scaffold
    摘要:
    Fibroblast activation protein (FAP) is a serine protease that is generally accepted to play an important role in tumor growth and other diseases involving tissue remodeling. Currently there are no FAP inhibitors with reported selectivity toward both the closely related dipeptidyl peptidases (DPPs) and prolyl oligopeptidase (PREP). We present the discovery of a new class of FAP inhibitors with a N-(4-quinolinoyl)-Gly-(2-cyanopyrrolidine) scaffold. We have explored the effects of substituting the quinoline ring and varying the position of its sp(2) hybridized nitrogen atom. The most promising inhibitors combined low nanomolar FAP inhibition and high selectivity indices (>10(3)) with respect to both the DPPs and PREP. Preliminary experiments on a representative inhibitor demonstrate that plasma stability, kinetic solubility, and log D of this class of compounds can be expected to be satisfactory.
    DOI:
    10.1021/ml300410d
  • 作为产物:
    描述:
    4-氯靛红sodium pyruvate 在 sodium hydroxide 作用下, 以 为溶剂, 生成 5-氯喹啉-2,4-二羧酸
    参考文献:
    名称:
    Selective Inhibitors of Fibroblast Activation Protein (FAP) with a (4-Quinolinoyl)-glycyl-2-cyanopyrrolidine Scaffold
    摘要:
    Fibroblast activation protein (FAP) is a serine protease that is generally accepted to play an important role in tumor growth and other diseases involving tissue remodeling. Currently there are no FAP inhibitors with reported selectivity toward both the closely related dipeptidyl peptidases (DPPs) and prolyl oligopeptidase (PREP). We present the discovery of a new class of FAP inhibitors with a N-(4-quinolinoyl)-Gly-(2-cyanopyrrolidine) scaffold. We have explored the effects of substituting the quinoline ring and varying the position of its sp(2) hybridized nitrogen atom. The most promising inhibitors combined low nanomolar FAP inhibition and high selectivity indices (>10(3)) with respect to both the DPPs and PREP. Preliminary experiments on a representative inhibitor demonstrate that plasma stability, kinetic solubility, and log D of this class of compounds can be expected to be satisfactory.
    DOI:
    10.1021/ml300410d
点击查看最新优质反应信息

文献信息

  • [EN] NOVEL FAP INHIBITORS<br/>[FR] NOUVEAUX INHIBITEURS DE FAP
    申请人:UNIV ANTWERPEN
    公开号:WO2013107820A1
    公开(公告)日:2013-07-25
    The present invention relates to novel inhibitors having high selectivity and specificity for FAP (fibroblast activation protein). Said inhibitors are useful as a human and/or veterinary medicine, in particular for the treatment and/or prevention of FAP-related disorders such as but not limited to proliferative disorders.
    本发明涉及对FAP(成纤维细胞活化蛋白)具有高选择性和特异性的新型抑制剂。所述抑制剂可用作人类和/或兽药,特别是用于治疗和/或预防FAP相关疾病,如但不限于增殖性疾病。
  • NOVEL FAP INHIBITORS
    申请人:UNIVERSITEIT ANTWERPEN
    公开号:US20140357650A1
    公开(公告)日:2014-12-04
    The present invention relates to novel inhibitors having high selectivity and specificity for FAP (fibroblast activation protein). Said inhibitors are useful as a human and/or veterinary medicine, in particular for the treatment and/or prevention of FAP-related disorders such as but not limited to proliferative disorders.
    本发明涉及具有高选择性和特异性的新型抑制剂,用于FAP(成纤维细胞激活蛋白)。所述抑制剂可用作人类和/或兽医药物,特别用于治疗和/或预防与FAP相关的疾病,如但不限于增殖性疾病。
  • The Synthesis of Potential Antimalarials. 7-Chloro-α-(2-piperidyl)-4-quinolinemethanol<sup>1</sup>
    作者:A. E. Senear、Herbert Sargent、J. F. Mead、J. B. Koepfli
    DOI:10.1021/ja01216a084
    日期:1946.12
  • US4009020A
    申请人:——
    公开号:US4009020A
    公开(公告)日:1977-02-22
  • US9346814B2
    申请人:——
    公开号:US9346814B2
    公开(公告)日:2016-05-24
查看更多